Although the molecular mechanism of LMO4–LDB1 complex formation in carcinoma dedifferentiation is not clearly defined yet, LMO4 acts as a dominant negative by interacting with LDB1, thereby competing for binding between LDB1 and transcription factors. This evidence concerns the gene LDB1 and carcinoma.